Literature DB >> 23148480

Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.

Jessica Barochiner1, José Alfie, Lucas S Aparicio, Paula E Cuffaro, Marcelo A Rada, Margarita S Morales, Carlos R Galarza, Gabriel D Waisman.   

Abstract

We assessed prevalence and clinical characteristics of resistant hypertension (RH) and prevalence of false RH (white-coat effect [WCE] by home blood pressure [BP] monitoring), among a population of 302 treated hypertensive patients, mean age 66.6 (± 13.8), 67.5% women. Resistant hypertension was defined according to the American Heart Association criteria. Prevalence of RH was 10%, and the following five variables were independently associated with it: body mass index, diabetes, isolated systolic hypertension, orthostatic hypotension, and use of beta-blockers. Prevalence of WCE among subjects with office-RH was 27.6%. Our study identified easily measurable parameters related to RH. Standing BP should be systematically measured in individuals with RH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148480     DOI: 10.3109/10641963.2012.739236

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  3 in total

1.  Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Am Soc Hypertens       Date:  2013-07-23

2.  Prevalence and characteristics of resistant hypertensive patients in an Asian population.

Authors:  Rabia Naseem; Arsalan Majeed Adam; Fiza Khan; Adiya Dossal; Ibrahim Khan; Ammara Khan; Hannah Paul; Hafsa Jawed; Aisha Aslam; Faez Muhammad Syed; Muhammad Ahsen Niazi; Shehzeen Nadeem; Aruba Khan; Amber Zia; Mohammad Hussham Arshad
Journal:  Indian Heart J       Date:  2017-01-26

3.  Detecting Risk Of Postural hypotension (DROP): derivation and validation of a prediction score for primary care.

Authors:  Christopher Elles Clark; Daniel Thomas; Fiona C Warren; David J Llewellyn; Luigi Ferrucci; John L Campbell
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.